A 58-year-old male patient with a long history of DM (over 10 years), currently treated with metformin, long-acting insulin analog, glucagon-like peptide-1 receptor agonist (GLP-1 Ra), and sodium-glucose co-transporter 2 inhibitors (SGLT2i). Here, GLP1R is linked to diabetes mellitus.